The Liver Meeting Debrief 2: Basic Science, Hepatitis, Hepatocellular Carcinoma, Cholestatic Liver Disease, Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol-Associated Liver Disease, and MetALD
Nov
2026
Description
The debrief sessions summarize the highest impact papers addressing key topics across the field of hepatology presented during The Liver Meeting. A group of original research reports reflecting major advances in hepatology are succinctly reviewed. Debrief 2 addresses basic science research, hepatitis, hepatocellular carcinoma, cholestatic liver disease, metabolic dysfunction–associated liver disease, alcohol-associated liver disease, and MetALD.
Presentations
8:00 AM
- 8:25 AM
Convention Center - General Session, Hall A
Basic Science Debrief
Yasuko Iwakiri, PhD, FAASLD | Presenter
8:50 AM
- 9:15 AM
Convention Center - General Session, Hall A
Cholestatic Liver Disease Debrief
Craig S Lammert, MD, MS, | Presenter
9:15 AM
- 9:40 AM
Convention Center - General Session, Hall A
Hepatocellular Carcinoma Debrief
Patricia Jones | Presenter
9:40 AM
- 10:05 AM
Convention Center - General Session, Hall A
Alcohol-Associated Liver Disease and MetALD Debrief
Gene Y. Im, MD, , FAASLD | Presenter
10:05 AM
- 10:30 AM
Convention Center - General Session, Hall A
Metabolic Dysfunction–Associated Steatotic Liver Disease Debrief
Vincent Chen | Presenter
8:25 AM
- 8:50 AM
Convention Center - General Session, Hall A
Hepatitis Debrief
Robert Gish, MD, FAASLD | Presenter